payday loans
payday loans
Skip to content

Accueil FMC Bibliographie
Listing des derniers articles parus

Dans cette rubrique on vous propose une revue de la littérature à travers une sélection d'abstracts d'articles originaux.
On essaiera de vous tenir informé des dernières nouveautés de recherche en matière de Pneumologie. On ne vous fournit que le résumé de l'article et le lien correspondant, pour accéder à l'article en full text vous devez être inscrits à la revue correspondante.
Cliquez ici pour consulter la liste des revues de Pneumologie disponibles en libre accès.

Filtrer par titres     Affichage # 
# Titre de l'article
251 [Mechanisms of non-specific airway hyperresponsiveness: Methacholine-induced alterations in airway architecture].
252 Management of children with interstitial lung diseases: the difficult issue of acute exacerbations
253 Occupational hypersensitivity pneumonitis: An EAACI Position paper.
254 Smoke-free legislation has potential to reduce the harmful effects of tobacco smoke exposure
255 Management of interstitial lung disease associated with connective tissue disease.
256 The role and choice criteria of antihistamines in allergy management - expert opinion.
257 Endoscopic Lung Volume Reduction: An Expert Panel Recommendation.
258 IFN-λ: A New Inducer of Local Immunity against Cancer and Infections.
259 Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
260 DNA damage and repair capacity in lymphocyte of chronic obstructive pulmonary diseases patients during physical exercise with oxygen supplementation
261 Physiological Mechanisms of Airways Hyperresponsiveness in Obese Asthma.
262 National Institutes of Health (NIH) Stroke Scale
263 Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis.
264 Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine.
265 Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results?
266 Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension.
267 Chemotherapy for Tuberculous Meningitis
268 New perspectives in the second-line treatment of non squamous NSCLC patients: Results from a large Italian Lung Cancer Working Group.
269 Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
270 Lung tumors, COPD and immune response: is epigenetics the bottom line?
271 Percutaneous Rotational Pulmonary Thrombectomy
272 Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis.
273 Environmental Microbial Exposure and Protection against Asthma
274 Local lung deposition of ultrafine particles in healthy adults: experimental results and theoretical predictions.
275 Bridging Lung Development with Chronic Obstructive Pulmonary Disease. Relevance of Developmental Pathways in Chronic Obstructive Pulmonary Disease Pathogenesis
276 Lung cancer: a rare indication for, but frequent complication after lung transplantation.
277 Lung sarcoidosis: Clinical features and therapeutic issues.
278 Non-Invasive Assessment of Pulmonary Vascular Resistance in Pulmonary Hypertension: Current Knowledge and Future Direction.
279 Comparative Study of Autoantibody Responses between Lung Adenocarcinoma and Benign Pulmonary Nodules.
280 Periostin: The bone and beyond.
281 Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathways.
282 Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
283 Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias.
284 FDG-PET parameters predicting mediastinal malignancy in lung cancer.
285 Lung-gut crosstalk: evidence, mechanisms and implications for the mucosal inflammatory diseases.
286 Genetic Modification of the Lung Directed Toward Treatment of Human Disease.
287 Allergen immunotherapy for insect venom allergy: protocol for a systematic review.
288 Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?
289 Molecular testing patterns in metastatic non-small cell lung cancer.
290 New Therapies for Asthma and COPD.
291 Indoor microbial communities: Influence on asthma severity in atopic and nonatopic children
292 How Do Dual Long-acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
293 International Consensus on Allergen Immunotherapy II: Mechanisms, standardization, and pharmacoeconomics
294 Nebulized antibiotics in mechanically ventilated patients: roadmap and challenges.
295 Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
296 Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep.
297 Sublingual or subcutaneous immunotherapy for allergic rhinitis?
298 Epigenetic dysfunctional diseases and therapy for infection and inflammation.
299 The microbial environment and its influence on asthma prevention in early life
300 Shifting from tuberculosis control to elimination: Where are we? What are the variables and limitations? Is it achievable?
 
<< Début < Précédent 1 2 3 4 5 6 7 8 9 10 Suivant > Fin >>
Page 6 sur 198

find-us-on-facebook-2

United4LungHealth

image001

World Allergy Week 2017 The Agony of Hives

WCOPDday2017



PubMed Logo
Word

 To: 

Langtolang Dictionary

CNP2014Ebook

50x50_firefoxsafari_iconGchrome


Notre site est optimisé pour les Navigateurs suivants : Firefox, Safari et Google Chrome. Cliquez sur l'un des logos ci-dessus pour le télécharger et l'installer gratuitement.

Tabac

Accueil FMC Bibliographie Top